Clinical Trial Update: AntiThrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating anti-thrombotic therapy to reduce complications in community-acquired pneumonia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Drugs mentioned

• AntiThrombotic Therapy

Snippet

Sponsor: University of Manitoba | Conditions: Community-acquired Pneumonia | Phase 3 | Status: RECRUITING